AKYA - Balance Sheet - Akoya Biosciences, Inc.

Current Liabilities	29.4 M
Accounts Payable	8.76 M
Short-Term Debt	3.28 M
Other Current Liabilities	17.4 M
Non-Current Liabilities	88 M
Long-Term Debt	80.9 M
Other Non-Current Liabilities	7.1 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
ASSETS
Cash & Cash Equivalents	11.8	83.1	74.2	113.1	17.0	11.6
Short Term Investments	23.3	0	7.0	0	0	10.0
Receivables	13.8	17.0	9.7	9.4	6.5	13.2
Inventory	24.3	17.9	14.5	9.0	4.3	4.1
Other Current Assets	3.6	3.8	6.8	13.5	1.0	2.0
Total Current Assets	76.7	121.8	112.2	140.8	28.7	40.9
PP&E	13.0	20.7	22.4	7.5	5.5	5.0
Intangible Assets	14.6	17.4	20.0	21.1	22.7	24.1
Goodwill	18.3	18.3	18.3	18.3	18.3	18.3
Long Term Investments	0	0	0.3	0.3	0.5	0.5
Other Long Term Assets	2.5	2.2	3.1	3.2	2.5	1.2
Other Assets	0	0	0	0	0	0
Total Assets	125.0	180.4	176.0	190.9	77.7	89.4
LIABILITIES
Accounts Payable	8.8	11.8	10.6	9.4	5.1	8.1
Short Term Debt	3.3	3.4	7.3	0.5	1.2	80 K
Other Current Liabilities	10.8	13.4	12.9	13.2	7.0	8.6
Total Current Liabilities	29.4	35.3	37.1	27.7	17.2	21.2
Long Term Debt	80.9	82.3	72.2	32.7	33.8	24.7
Deferred Tax Income	0.1	38 K	87 K	26 K	0.2	0.2
Other Liabilities	3.9	5.8	6.0	7.8	7.0	72.7
Total Liabilities	117.4	126.6	117.5	69.6	59.1	119.6
EQUITY
Common Stock	2 K	2 K	2 K	2 K	2 K	1 K
Retained Earnings	(285.4)	(230.1)	(166.7)	(96.1)	(52.3)	(31.4)
Other Accumulative Comprehensive Income/Loss	7 K	0	6 K	(190.9)	(70.4)	1 K
Total Equity	7.6	53.8	58.6	121.4	18.6	(30.2)
Total Liabilities and Equity	125.0	180.4	176.0	190.9	77.7	89.4
SHARES OUTSTANDING
Common Shares Outstanding	49.4	44.4	37.7	37.4	37.1	37.1

Free